ZEPP Zepp Health Corporation

  1. Stocks
  2. Technology
  3. NYSE: ZEPP

Price (delayed)

$3.98

Market cap

$62.52M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.72

Enterprise value

$202.23M

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 3
Relative Valuation: Rel. Valuation: 37
Relative Profitability: Rel. Profitability: 33

Zepp Health Corporation is a global leader in smart wearables and health technology, empowering users to live their healthiest lives by optimizing their health, fitness, and wellness journeys through its ...

Highlights
The company's gross profit rose by 42% YoY and by 2.1% QoQ
ZEPP's revenue is up by 38% YoY
Zepp Health's net income has increased by 44% YoY but it has decreased by 9% from the previous quarter
The EPS rose by 43% YoY but it fell by 6% QoQ
ZEPP's debt is up by 27% YoY and by 2.7% from the previous quarter
Zepp Health's equity has decreased by 18% YoY and by 4.7% from the previous quarter
Sector: Technology
Industry: Consumer Electronics
Website: https://www.huami.com
Peers: AAPL GRMN GPRO JBL

Key stats

What are the main financial stats of ZEPP

ZEPP stock price

How has the Zepp Health stock price performed over time
Intraday
0.51%
1 week
-3.86%
1 month
-18.11%
1 year
-91.98%
YTD
-85.23%
QTD
-1%

Financial performance

How have Zepp Health's revenue and profit performed over time
Revenue
$276.03M
Gross profit
$106.5M
Operating income
-$34.75M
Net income
-$43.56M
Gross margin
38.6%
Net margin
-15.8%
ZEPP's net margin has soared by 59% YoY but it is down by 7% from the previous quarter
ZEPP's operating margin is up by 45% year-on-year but it is down by 20% since the previous quarter
Zepp Health's net income has increased by 44% YoY but it has decreased by 9% from the previous quarter
The company's gross profit rose by 42% YoY and by 2.1% QoQ

Price vs fundamentals

How does ZEPP's price correlate with its fundamentals

Growth

What is Zepp Health's growth rate over time

Valuation

What is Zepp Health stock price valuation
P/E
N/A
P/B
0.34
P/S
0.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.73
The EPS rose by 43% YoY but it fell by 6% QoQ
ZEPP's price to book (P/B) is 79% less than its last 4 quarters average of 1.6 and 43% less than its 5-year quarterly average of 0.6
Zepp Health's equity has decreased by 18% YoY and by 4.7% from the previous quarter
The P/S is 84% below the last 4 quarters average of 1.4 and 54% below the 5-year quarterly average of 0.5
ZEPP's revenue is up by 38% YoY

Efficiency

How efficient is Zepp Health business performance
The ROS has soared by 57% YoY but it fell by 9% QoQ
The return on assets has increased by 45% year-on-year but it has declined by 8% since the previous quarter
The return on invested capital has grown by 38% year-on-year but it has declined by 11% since the previous quarter
The company's return on equity rose by 30% YoY but it fell by 14% QoQ

Dividends

What is ZEPP's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Zepp Health financials performed over time
ZEPP's total assets is 49% greater than its total liabilities
The company's current ratio fell by 18% YoY but it rose by 2.3% QoQ
ZEPP's total liabilities is up by 16% year-on-year and by 11% since the previous quarter
ZEPP's debt is 33% more than its equity
Zepp Health's debt to equity has surged by 55% YoY and by 8% QoQ
ZEPP's debt is up by 27% YoY and by 2.7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.